Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel Napadisilate vs Bisulfate in CAD
NCT01830491Phase 4Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Mar 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of clopidogrel napadisilate in coronary artery disease (CAD), sponsored by Hanmi Pharmaceutical. Started Mar 2009; status: completed.
02
Drugs
clopidogrel napadisilate
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01830491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01830491.